Food Effect on Oral Paclitaxel with Encequidar in Advanced Solid Tumors

Phase 1, randomised, open-label trial of paclitaxel oral solution and encequidar in solid tumor (2 arms), sponsored by Health Hope Pharma. Primary endpoints: Area under the plasma concentration-time curve from 0 to time of last quantifiable concentration and Area under the plasma concentration-time curve from time 0 to infinity. Planned start May 2026; status: not yet recruiting.